Xilio Therapeutics (XLO) Notes Payables (2020 - 2023)
Xilio Therapeutics (XLO) posted Notes Payables of $3.3 million for Q4 2023, down 33.12% sequentially from $5.0 million in Q3 2023, and down 50.28% YoY from $6.7 million in Q4 2022.
Xilio Therapeutics (XLO) Notes Payables (2020 - 2023) Analysis & Trends
Xilio Therapeutics has reported Notes Payables for 3 years, with the latest figure at $3.3 million in Q4 2023.
- Quarterly Notes Payables fell 50.28% year-over-year to $3.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.3 million (down 50.28% YoY) and the FY2023 annual result came in at $3.3 million, down 50.28% from the prior year.
- Notes Payables eased to $3.3 million in Q4 2023 per XLO's latest filing, from $5.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $7.1 million in Q2 2023 and troughed at $1.7 million in Q1 2022.
- A 3-year average of $4.6 million and a median of $5.0 million in 2023 frame the typical range for Notes Payables.
- The widest YoY moves for Notes Payables: up 299.94% in 2023, down 50.28% in 2023.
- Over 3 years, Notes Payables stood at $2.3 million in 2020, then soared by 185.77% to $6.7 million in 2022, then sank by 50.28% to $3.3 million in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $3.3 million, $5.0 million, and $7.1 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Xilio Therapeutics | 177.75 Mn | 41.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 4.96 Mn |
| Jun 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 6.67 Mn |
| Dec 31, 2022 | 6.67 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 3.33 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2020 | 2.33 Mn |